For Doctors in a Hurry
- Researchers investigated whether extracorporeal cardiopulmonary resuscitation improves outcomes for pediatric patients following out-of-hospital cardiac arrest compared to conventional resuscitation.
- This retrospective cohort study analyzed 799 Japanese pediatric patients, matching 27 who received extracorporeal life support with 108 control patients.
- Extracorporeal resuscitation yielded a 25.9 percent survival rate versus 11.1 percent for conventional methods (risk ratio 3.56; 95 percent confidence interval 1.37-9.28).
- The researchers concluded that extracorporeal life support might improve survival and neurologic outcomes, although wide confidence intervals limited the statistical precision.
- These findings suggest that while extracorporeal methods show potential, randomized controlled trials are necessary to confirm efficacy in pediatric cardiac arrest.
Refractory out-of-hospital cardiac arrest (OHCA) remains a significant cause of pediatric mortality, often leaving clinicians with few options when standard advanced life support fails. While extracorporeal cardiopulmonary resuscitation (ECPR) provides temporary circulatory support, evidence from adult randomized trials has been inconsistent regarding its effect on long-term neurologic outcomes [1, 2, 3]. Meta-analyses in adults suggest that any survival benefit is more pronounced for in-hospital arrests than for OHCA [4, 5]. The evidence base for the pediatric population is even more sparse, consisting mainly of data from in-hospital settings or small observational series [6, 7]. A new multicenter registry analysis from Japan now provides a direct comparison of ECPR versus continued conventional resuscitation for children experiencing cardiac arrest in the community.
Registry Analysis and Risk-Set Matching
To investigate this issue, researchers conducted a retrospective cohort study using data from a Japanese OHCA registry collected between 2014 and 2022. The analysis included 799 patients younger than 18 years who were transported to pediatric ECPR-capable institutions. The central comparison was between patients who received ECPR and those who only received continued conventional cardiopulmonary resuscitation (CPR). To mitigate the selection biases inherent in an observational study, the authors employed a sophisticated statistical technique. They dynamically matched each patient receiving ECPR with up to four control patients who, at that specific moment in their resuscitation, had not yet received ECPR but remained eligible for it. This method, known as risk-set matching with time-dependent propensity scores, helps ensure that the comparison groups are as similar as possible at the time the treatment decision is made, approximating the balance of a randomized trial.
From the total cohort, 27 patients received ECPR. The matching process yielded a comparison group of 108 at-risk controls. The ECPR group was composed primarily of adolescents (median age 14 years), and their arrests were frequently witnessed (70.4%) and of cardiogenic etiology (74.1%). After the matching procedure, the baseline clinical characteristics were similar between the ECPR and control groups, creating a balanced foundation for comparing outcomes. This specific patient profile may suggest a subpopulation for whom ECPR is most often considered and potentially most beneficial.
Survival and Neurologic Recovery Outcomes
The analysis focused on two primary clinical endpoints: survival at one month and favorable neurologic outcome. Neurologic status was quantified using the Pediatric Cerebral Performance Category scale, where scores of 1 to 3 represent a spectrum from normal function to moderate disability. The findings indicated a notable difference between the groups. One-month survival in the ECPR group was 25.9% (7 of 27 patients), compared to 11.1% (12 of 108 patients) in the control group that received continued conventional CPR. This corresponds to a risk ratio for survival of 3.56 (95% CI, 1.37 to 9.28) and an absolute risk difference of 17.3% (95% CI, -0.9 to 35.6).
Neurologic recovery showed a similar pattern. A favorable neurologic outcome was achieved by 18.5% of patients receiving ECPR (5 of 27), versus 6.5% of controls (7 of 108). This translated to a risk ratio of 3.78 (95% CI, 1.19 to 11.99) and an absolute risk difference of 13.9% (95% CI, -2.9 to 30.8). While the point estimates for both survival and neurologic function suggest a clinically meaningful benefit associated with ECPR, the authors caution that the wide confidence intervals limit the precision of these estimates. The potential for residual confounding factors, which are unmeasured variables that can influence outcomes, also remains a key limitation of this observational design.
Clinical Interpretation and Statistical Precision
Although the results point toward a substantial clinical benefit, the statistical precision is limited, a fact underscored by the wide confidence intervals. For one-month survival, the 95% confidence interval for the risk difference (-0.9% to 35.6%) crossed the null value of zero, meaning a finding of no difference cannot be statistically excluded. The same was true for the neurologic outcome (95% CI, -2.9% to 30.8%). This statistical imprecision is a direct consequence of the small number of ECPR cases (n=27) available for analysis in the registry, a common challenge in studying rare pediatric emergencies.
Furthermore, the authors highlight the potential for residual confounding, a common limitation in observational research where unmeasured factors may influence the results. Even with advanced statistical matching, variables not captured in the registry, such as the specific time from arrest to ECPR initiation or institutional differences in post-resuscitation care, could have affected outcomes. For the practicing physician, these findings provide the first comparative data for ECPR in pediatric OHCA, suggesting a potential survival advantage, particularly for adolescents with witnessed, cardiogenic arrests. However, the study's primary contribution may be to inform the design of future randomized controlled trials. Until such trials provide more definitive evidence, the decision to pursue ECPR will continue to rely on institutional resources and expert clinical judgment, now supported by this signal of potential benefit.
References
1. Gomes DA, Presume J, Ferreira J, et al. Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a systematic review and meta-analysis of randomized clinical trials.. Internal and emergency medicine. 2023. doi:10.1007/s11739-023-03357-x
2. Scquizzato T, Bonaccorso A, Swol J, et al. Refractory out-of-hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: A meta-analysis of randomized trials.. Artificial organs. 2023. doi:10.1111/aor.14516
3. Suverein MM, Delnoij T, Lorusso R, et al. Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest. New England Journal of Medicine. 2023. doi:10.1056/nejmoa2204511
4. Low CJW, Ramanathan K, Ling RR, et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis.. The Lancet. Respiratory medicine. 2023. doi:10.1016/S2213-2600(23)00137-6
5. Ahn C, Kim W, Cho Y, Choi K, Jang B, Lim T. Efficacy of extracorporeal cardiopulmonary resuscitation compared to conventional cardiopulmonary resuscitation for adult cardiac arrest patients: a systematic review and meta-analysis. Scientific Reports. 2016. doi:10.1038/srep34208
6. Holmberg MJ, Geri G, Wiberg S, et al. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: A systematic review.. Resuscitation. 2018. doi:10.1016/j.resuscitation.2018.07.029
7. Holmberg MJ, Granfeldt A, Guerguerian A, et al. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: An updated systematic review. Resuscitation. 2022. doi:10.1016/j.resuscitation.2022.12.003
